(499000) ACE Symposium: ICU Management of HRS/AKI and Multiorgan Failure in Patients With Decompensating Cirrhosis - This program is supported by an educational grant from Mallinckrodt Pharmaceuticals

Monday, January 22, 2024

12:10 PM – 1:25 PM MT

Location: North-121

Symposium Moderator(s)

Constantine Karvellas, MD, MS, FCCM (he/him/his)

Professor
University of Alberta
Edmonton, AB, Canada

Symposium Faculty(s)

Jody C. Olson, MD, FACP, FCCM (he/him/his)

Mayo Clinic Rochester
Rochester, Minnesota
Ram M. Subramanian, MBA, MD, FCCM

Professor of Medicine & Surgery
Emory University
Atlanta, Georgia

Disclosure(s):

Jody Olson, MD, FACP, FCCM: Mallinckrodt: Advisory Board (Terminated, November 3, 2022), Consulting fees or other remuneration (Terminated, November 3, 2022)

Ram M. Subramanian, MBA, MD, FCCM: Baxter: Consultant (Terminated)

This educational platform is intended to improve the identification and management of patients with or at high risk for developing secondary diseases such as HRS/AKI as a result of decompensating cirrhosis or acute-on-chronic liver failure, the multiorgan failure syndrome induced by specific triggers in patients with decompensated cirrhosis. Guided by a comprehensive assessment of current gaps in clinical practice, content is intended for SCCM Congress attendees to provide effective care based on available evidence, guidelines, and expert best practices.

Learning Objectives:

Describe the different etiologies of acute kidney injury (AKI) arising in cirrhosis and how they impact treatment and outcomes
Apply guideline-recommended vasoconstrictor therapy for patients who meet diagnostic criteria for hepatorenal syndrome/AKI
Discuss the comprehensive management of patients with severe multiorgan disease (acute-on-chronic liver failure grade 3) in the ICU and the implications for liver transplant